NCT00159614已完成2 期
Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With Congestive Heart Failure (CHF) and Renal Impairment
NovaCardia, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)6 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2005年9月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
- 试验地点
- 6
- 主要终点
- Comparison of KW-3902IV alone or with loop diuretic on renal function.
研究概览
简要总结
The purpose of this study is to characterize the safety and tolerability of KW-3902IV and measure its effect on renal function.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Stable congestive heart failure
- •Impaired renal function
- •Taking oral loop diuretic
排除标准
- •Acutely decompensated (unstable) and end stage heart failure
- •Diuretics other than loop diuretics
- •Pregnant or nursing
- •Inability to follow instructions
- •Participation in another clinical trial within past 30 days
结局指标
主要结局
Comparison of KW-3902IV alone or with loop diuretic on renal function.
次要结局
未报告次要终点
研究者
研究点 (6)
Loading locations...
相似试验
终止
2 期
Ph1b/2 Study of PF-04136309 in Combination With Gem/Nab-P in First-line Metastatic Pancreatic PatientsMetastatic Pancreatic Ductal AdenocarcinomaNCT02732938Pfizer22
已完成
1 期
A Study of KW-3357 in Congenital Antithrombin DeficiencyCongenital Antithrombin DeficiencyNCT00938288Kyowa Kirin Co., Ltd.16
已完成
1 期
Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and NeutropeniaFeverMycosesNeutropeniaNCT00001790National Cancer Institute (NCI)120
已完成
1 期
Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected CancersHead and Neck CancerMicrosatellite-instability (MSI) High Colorectal Cancer (CRC)Endometrial CancerRenal Cell Carcinoma (RCC)Hepatocellular Carcinoma (HCC)Solid TumorsUC (Urothelial Cancer)Triple Negative Breast Cancer (TNBC)Lung CancerOvarian CancerLymphomaGastric CancerMelanomaBladder CancerNCT02178722Incyte Corporation444
撤回
1 期
Frespaciguat (MK-5475) in Participants With Hypoxemia Due to COVID-19 Pneumonia (MK-5475-009)Coronavirus Disease 2019 (COVID-19)HypoxemiaPneumoniaNCT04425733Merck Sharp & Dohme LLC